Previous Article | Next Article ![]()
Applied and Environmental Microbiology, September 2001, p. 3873-3881, Vol. 67, No. 9
Department of Bioscience, University of
Strathclyde,1 and Department of
Bacteriology and Immunology, University of Glasgow Medical School,
Glasgow Royal Infirmary,2 Glasgow, Scotland
Received 22 November 2000/Accepted 30 May 2001
Forty-seven strains representing 14 different
Bacillus species isolated from clinical and food samples
were grown in reconstituted infant milk formulae (IMF) and subsequently
assessed for adherence to, invasion of, and cytotoxicity toward HEp-2
and Caco-2 cells. Cell-free supernatant fluids from 38 strains (81%)
were shown to be cytotoxic, 43 strains (91%) adhered to the test cell
lines, and 23 strains (49%) demonstrated various levels of invasion. Of the 21 Bacillus cereus strains examined, 5 (24%)
were invasive. A larger percentage of clinically derived
Bacillus species (20%) than of similar species tested
from the food environment were invasive. Increased invasion
occurred after growth of selected Bacillus species in
reconstituted IMF containing glucose. While PCR primer studies revealed
that many different Bacillus species contained DNA
sequences encoding the hemolysin BL (HBL) enterotoxin complex and
B. cereus enterotoxin T, not all of these
isolates expressed these diarrheagenic genes after growth in
reconstituted IMF. Of the 47 Bacillus isolates examined,
3 isolates of B. cereus and 1 isolate of
B. subtilis produced the HBL enterotoxin after 18 h of growth in brain heart infusion broth. However, eight
isolates belonging to the species B. cereus,
B. licheniformis, B. circulans, and B. megaterium were found to produce this
enterotoxin after growth in reconstituted IMF when assessed with the
B. cereus enterotoxin (diarrheal type) reversed
passive latex agglutination (RPLA) kit. It is concluded that
several Bacillus species occurring occasionally in
clinical specimens and food samples are of potential medical significance due to the expression of putative virulence factors.
The bacterial genus
Bacillus comprises a very large and diverse group whose
members are found ubiquitously (2, 10, 22). With the
exception of Bacillus anthracis and B. cereus, other Bacillus species are generally perceived
as inconsequential and of little clinical significance
(8). Due to the endospore-forming ability of members of
this genus, these bacteria tolerate adverse conditions better than most
bacterial enteropathogens. They occur frequently in hospital
foods (21) and domestically prepared foods
(22).
Most food poisoning incidents attributed to Bacillus species
are associated with B. cereus; this bacterium is known
to cause a variety of nongastrointestinal diseases as well as two
different types of food poisoning (for reviews, see references
7, 10, 13, and 14),
which are characterized by either diarrhea or emesis. The diarrheal
type is attributed to heat-labile enterotoxins that cause cytotoxicity,
fluid accumulation in the ligated ileal loop of experimental animals,
and dermonecrosis and is lethal for mice (14, 17). Two
protein complexes from B. cereus strains, hemolysin BL
(HBL) and nonhemolytic enterotoxin (NHE), and an enterotoxic protein,
enterotoxin T (BceT), with these diarrheagenic properties have been
previously characterized (3, 11, 14, 25). The emetic type
is caused by a heat-stable dodecadepsipeptide, cereulide (14). The relevance of other
Bacillus species as food poisoning organisms is being
increasingly recognized, with recent epidemiological evidence linking
B. licheniformis, B. subtilis, B. pumilus, and B. thuringiensis with incidents of food-borne illness (8). Previous research has shown that a
variety of different Bacillus species isolated from the
dairy environment may have the potential to produce diarrheal
enterotoxins (2). Beattie and Williams (2)
recently showed that supernatant fluids from isolates of B. thuringiensis, B. circulans,
B. licheniformis, B. lentus,
B. laterosporus, and B. mycoides
reacted positively with the commercially available Bacillus
diarrheal enterotoxin (BDE) visual immunoassay (Tecra VIA;
International Bioproducts Inc., Redmond, Wash.) and the
B. cereus enterotoxin (diarrheal type) reversed passive
latex agglutination (RPLA) kit (Oxoid Ltd., Basingstoke, England).
Many members of the genus Bacillus have also been shown to
be the etiological agents in local, deep-tissue, and systemic
infections (8, 15). Nongastrointestinal infections have
been primarily seen in individuals who are intravenous drug abusers or
immunocompromised as a consequence of human immunodeficiency virus
infection, chemotherapy, or malignancy (2). Due to the
marked involvement of the liver and spleen with a brevity of
gastrointestinal symptoms, the possibility that these systemic
infections may have resulted from bacterial translocation from the
gastrointestinal tract has been raised (8). While
Bacillus spp. have been associated with human illnesses, the
virulence status of many members of this genus has yet to be defined.
We report on the ability of different clinical and food isolates of
Bacillus to adhere to, invade, and produce a cytotoxic effect in human HEp-2 and Caco-2 epithelial cells after growth in
commercially produced baby foods. We also report that the ability of
selected Bacillus isolates to express diarrheal enterotoxins HBL and BceT after growth in baby foods was influenced by the nutritional compositions of the products.
Bacterial strains and growth media.
The Bacillus
strains (Table 1) used in this study
were, if not otherwise indicated, obtained from the Department of
Bacteriology, Glasgow Royal Infirmary, Glasgow, Scotland (GRI); from
Yorkhill Hospital, Glasgow, Scotland (YH); from the Food Safety
Microbiology Laboratory, Central Public Health Laboratory,
Colindale, United Kingdom (PHLS); from the Hannah Dairy
Research Institute, Ayr, Scotland (HDRI); and from the National
Collection of Type Cultures, Central Public Health Laboratory,
Colindale, United Kingdom (NCTC). Other Bacillus strains
were isolated from reconstituted infant milk formulae (IMF),
pasteurized milk, enteral feeds, and high-energy buildup foods.
Listeria monocytogenes NCTC 11994 was used as a positive
control for bacterial adherence and invasion studies. The identity of
each Bacillus isolate was confirmed by performing a sequence
of characteristic morphological and physiological tests as described
previously (22) and by use of miniaturized biochemical API
50CHB and API 20E galleries (bioMérieux, Marcy l'Etiole, France).
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.9.3873-3881.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Putative Virulence Factor Expression by Clinical and Food
Isolates of Bacillus spp. after Growth in Reconstituted
Infant Milk Formulae
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Bacterial strains used
70°C (Microbank System, Pro-Lab Diagnostics,
Ontario, Canada) to prevent the loss of virulence characteristics.
Adherence and invasion assays.
The ability of
Bacillus test strains to adhere to and invade HEp-2 and
Caco-2 cells was determined by previously described procedures
(19), with minor modifications. HEp-2 and Caco-2 cell
monolayers were grown overnight in a 5% CO2
atmosphere at 37°C in DMEM supplemented with 10% fetal calf serum
(FCS; Gibco BRL) in 24-well tissue culture plates seeded with
approximately 105 cells per well. Prior to
assays, the monolayers were washed three times with DMEM, inoculated
with 1 ml of bacterial culture (in DMEM with 10% FCS) in triplicate,
and incubated for 2 h at 37°C in a 5% CO2
atmosphere. After incubation, the monolayers were washed three times
with DMEM to remove any nonadherent cells, and then 1 ml of DMEM
containing 10% FCS was added to each well of one of the test plates
and incubated for 2 h. For the invasion assays, 1 ml of DMEM
containing 10% FCS and 100 µg of gentamicin ml
1 was added to each well of the other 24-well
plate and incubated for 2 h. The monolayers were then washed three
times with DMEM, and the tissue culture cells were lysed with 1 ml of
1% Triton X-100 (vol/vol in distilled water) for 5 min
at 37°C. Samples (0.1 ml) of lysate from each tissue culture plate
were serially diluted in 0.9 ml of sterile distilled water, with
subsequent enumeration by plating of 20 µl of appropriate
10-fold dilutions on BHI agar plates.
Cell cytotoxicity assay
Assessment of
cytotoxic effects was made by measuring total cellular metabolic
activity using the tetrazolium salt
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT;
Sigma, Poole, United Kingdom). The cell cytotoxicity assay of Coote and
Arian (5) was used, with minor modifications. HEp-2 and
Caco-2 cell monolayers were grown overnight at 37°C in a 5%
CO2 atmosphere in DMEM supplemented with 10% FCS in
96-well microplates seeded with approximately 5 × 104
cells per well. Bacterial cultures were grown for 18 h as
described above, and 0.1-ml samples were filter sterilized
(0.2-µm-pore-size membranes; Sarstedt, Nümbrecht,
Germany). Samples were added in triplicate to the test plate
immediately, after heating of the supernatant at 95°C for 10 min, or after enzymatic treatment with 0.1% trypsin. Positive and
negative assay controls were 1% Triton X-100 (Sigma) and
phosphate-buffered saline, respectively. Tissue culture monolayers
containing bacterial culture supernatants were incubated overnight at
37°C in a 5% CO2 atmosphere, followed by the addition of
phosphate-buffered saline containing 0.5% MTT to each well and
incubation for 4 h at 37°C. The suspension in the wells was then
removed, and the formazan product was solubilized by the addition of
100 µl of 0.04 HCl in dimethyl sulfoxide (Sigma). The contents of the
plates were measured spectrophotometrically at 540 nm with a microplate
reader (Labsystems EMS Reader). The toxic effects of the cell-free
bacterial culture supernatants on the HEp-2 and Caco-2 cell lines were
calculated from the following equation: (1
optical density of
test sample/optical density of negative control) × 100. Cytotoxic
effects produced in HEp-2 and Caco-2 cells were also confirmed by light microscopy.
Measurement of other virulence factors. All the isolates were tested for lecithinase (phosphatidylinositol-specific phospholipase C) activity after overnight growth on nutrient agar supplemented with 8% egg yolk (Oxoid) and by overlaying 1% L-d-phosphatidylinositol substrate (Sigma) in 0.7% agarose on overnight cultures of the bacteria on L agar plates. Lecithinase-positive strains produced a halo of precipitation (insoluble diacylglycerol) around the bacterial colonies. Production of catalase was assayed for by using an ID Color Catalase testing kit (bioMérieux). The ability of the isolates to induce hemolysis of 7% horse erythrocytes on blood agar was examined. In addition, hemolysis of 10% horse erythrocytes in BHI broth by the isolates was determined spectrophotometrically at 640 nm. The presence of diarrheal enterotoxin was measured using the B. cereus enterotoxin (diarrheal type) RPLA kit according to the manufacturer's instructions.
Screening of Bacillus spp. for the presence of bceT, hblA, hblC, and hblD enterotoxin DNA sequences by PCR. Chromosomal DNA was isolated from the test Bacillus spp. by a previously described procedure (4). The DNA sequences of the diarrheagenic genes bceT (1), hblC and hblA (23), and hblD (11) were used to design primers that would amplify segments of the genes, if present, in a selection of the above-mentioned test Bacillus strains. Amplification was carried out with a DNA thermal cycler for 36 cycles of 30 s at 94°C; 1 min at 54°C, 60°C, 62°C, and 65°C for the hblD, bceT, hblC, and hblA genes, respectively; and 1 min at 72°C. PCR products of 429, 617, 399, and 873 bp were detected when the following pairs of oligonucleotide primers were used, respectively: HBLD-N (5'-AATCAAGAGCTGTCACGAAT-3') and HBLD-C (5'-CACCAATTGACCATGCTAAT-3'), BCET6-N (5'-CATATGAAAGAGTTAGTTTCA-3') and BCET5-C (5'-CGGATGAGGTGAGAAATGAAC-3'), HBLA-N (5'-GCTAATGTAGTTTCACCTAGCAAC-3') and HBLA-C (5'-AATCATGCCACTGCGTGGACATATAA-3'), and HBLC-N (5'-AATAGGTACAGATGGAACAGG-3') and HBLC-C (5'-GGCTTTCATCAGGTCATACTC-3').
Statistical analysis. All studies were performed in triplicate, and averages and standard errors were determined. Differences in bacterial adherence, invasion, and cytotoxicity were examined with human epithelial HEp-2 and Caco-2 cells at the 95 or 99.9% confidence interval using analysis of variance (one-way or balanced model) with Minitab software, release 11 (Minitab Inc., State College, Pa.).
| |
RESULTS |
|---|
|
|
|---|
Forty-seven Bacillus isolates representing 14 different species from clinical and food environments were used in this study (Table 1). The human diseases associated with the clinical Bacillus isolates ranged from severe infections, such as spreading fasciitis (e.g., B. pumilus KD14), to less serious food-borne illnesses.
Confirmation of the identity of some of the Bacillus isolates to species level was problematic, as they showed atypical characteristics for a number of the physiological and biochemical tests. For instance, the clinical isolates B. licheniformis KD1 and KD8 and B. pumilus KD14 produced lecithinase, yet these species were previously reported to be unable to produce this phospholipase. Interestingly, B. licheniformis KD8 produced lecithinase at 37°C but not at the lower culture temperature of 30°C. All Bacillus species tested were shown to be catalase positive and, with the exception of B. firmus, were also shown to be hemolytic. Irrespective of the source of the organism, the commercially available API 50CHB system was unable to differentiate between B. licheniformis and the closely related B. subtilis.
Ability of Bacillus test isolates to adhere
to, invade, and produce cytotoxic effects in epithelial cells after
growth in laboratory-based culture media.
The ability of the
Bacillus test isolates to adhere to, invade, and produce
cytotoxic effects in Caco-2 and HEp-2 cells was assessed after 18 h of growth in BHI broth. While the results showed that there were
species-to-species variations in the levels of cytotoxicity produced,
the culture supernatant fluids from 38 Bacillus isolates
(81%, representing all 14 Bacillus species) had cytotoxic
effects in both epithelial cell lines (Table
2). Clinical Bacillus isolates
were significantly more cytotoxic to HEp-2 cells (P < 0.05); the mean toxicities of 19 clinical and food Bacillus
isolates were 70.7% ± 12% and 34.8% ± 24%, respectively (Table
2). While both cell lines were susceptible to the culture supernatant
fluids from many Bacillus isolates, some Bacillus spp. were cytotoxic to one cell line only. Other species, such as
B. megaterium NR73, B. subtilis NR106,
B. cereus DC1, and B. mycoides H1, were
shown to be noncytotoxic. Separate heat and trypsin treatments of
culture supernatant fluids either reduced or eliminated toxicity in
HEp-2 and Caco-2 cells, suggesting that the cytotoxic activity was
attributable to the proteinaceous fraction of the culture supernatant
fluids (Table 3).
|
|
Putative virulence factor expression by Bacillus
species after growth in reconstituted IMF.
The cytotoxicity,
adherence, and invasion potentials of a selection of
Bacillus species were assessed after 18 h of growth at
37°C in a variety of commonly used reconstituted IMF (Table 4). All of the Bacillus
isolates tested were capable of growth in a variety of reconstituted
IMF that differed in nutritional compositions. IMF 1 contained the
starch derivative maltodextrin and lactose, IMF 2 contained glucose
syrup and lactose, and IMF 3 and IMF 4 contained lactose. The results
showed that the cell-free culture supernatants from many of the
selected Bacillus isolates produced various levels of
cytotoxicity in HEp-2 cells (Table 4). While some Bacillus
species showed similar levels of toxicity after growth in all four IMF
and in BHI broth (such as B. cereus KD4 and
B. megaterium KD16), most Bacillus species
varied considerably (P < 0.05) in their ability to
elicit cytotoxicity in HEp-2 cells. Some Bacillus species
(such as B. licheniformis KD1, B. circulans KD9, and B. thuringiensis
KD3) were cytotoxic after growth in BHI broth but not after growth in
certain IMF (Table 4). Not all of the IMF used for growth of the
cytotoxigenic Bacillus species resulted in toxicity in HEp-2
cells.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This study constitutes the first demonstration that isolates of a wide variety of Bacillus spp., previously isolated from clinical specimens and food samples, are capable of adhering to, invading, and producing cytotoxic effects in human epithelial cells. Forty-seven Bacillus isolates were assessed for these putative virulence factors after growth in laboratory-based culture media and in baby foods. Production of the HBL enterotoxin complex was assessed using the B. cereus enterotoxin (diarrheal type) RPLA kit. Detection of DNA sequences encoding HBL enterotoxin and B. cereus BceT was achieved by PCR primer analysis.
With the exception of B. anthracis and B. cereus, which can be identified using rapid molecular and immunological approaches (12, 16), identification of other Bacillus isolates to the species level remains arduous, as it largely depends on performing a series of biochemical and physiological tests (8, 21, 22). Identification is further complicated by the fact that many clinical isolates of a species occasionally do not provide characteristic reactions that are considered typical of that species. For instance, during this study, the clinical isolates B. licheniformis KD1 and KD8 and B. pumilus KD14 were shown to be atypically lecithinase positive. Despite these constraints, all Bacillus isolates were identified to the species level. While the miniaturized biochemical API 50CHB assay was used to confirm the identity of each Bacillus species, this method was unable to differentiate between B. licheniformis and B. subtilis (in such instances, additional physiological discriminatory tests were performed).
Cell-free culture supernatants of 90 and 81% of the 47 Bacillus isolates examined for cytotoxicity in this study showed toxicity in HEp-2 and Caco-2 epithelial cells, respectively. Others have shown that the tetrazolium salt MTT can be used to assess the cytotoxic effects of culture supernatant fluids of Bacillus species isolated from raw milk (2, 9). Only living eukaryotic cells are detected using this assay, as the tetrazolium ring of MTT is cleaved in the mitochondria of metabolically active cells. Beattie and Williams (2) showed that some isolates of B. circulans, B. laterosporus, B. lentus, B. licheniformis, B. mycoides, B. subtilis, B. cereus, and B. thuringiensis were toxigenic to Chinese hamster ovary (CHO) cells using this MTT assay. Tetrazolium salts have also been used to assess the cytotoxicity of other pathogens, such as Pasteurella haemolytica A1 leukotoxin (6) and the cytotoxin of Campylobacter jejuni (5), and they were recently used to investigate B. cereus toxicity (26). Findlay et al. (9) advocated the use of MTT, as the currently used HEp-2 cell vacuolation assay for Bacillus emetic toxin is laborious, subjective, and unreliable.
This study also showed that greater detection of toxigenic Bacillus isolates occurred with different cell lines, as the culture supernatant fluids of some Bacillus species did not produce a cytotoxic effect in each of the cell lines investigated. In this study and another study (2), a higher proportion of toxigenic strains was detected by cytotoxicological methods. The apparent lower detection rate with immunological methods (Tecra BDE and Oxoid RPLA diarrheal enterotoxin test kits) is likely to be attributable to their specificity for individual components in the toxin complexes. This study showed that the supernatant fluids from isolates of B. licheniformis, B. subtilis, B. circulans, and B. megaterium were positive in the B. cereus enterotoxin (diarrheal type) RPLA assay, which is specific for the L2 component of the HBL complex. This finding indicates that these isolates produced protein toxins that were very similar to those of B. cereus and that these species may also present a potential hazard in food products. HBL contains the protein components B (37.5 kDa), L1 (38.2 kDa), and L2 (43.5 kDa), and all three components are required to produce maximal biological activity. The toxic activities so far identified for HBL include hemolysis, vascular permeability and necrosis in rabbit skin, fluid accumulation in rabbit ileal loops, toxicity to a number of transformed cell lines, in vitro degradation of explanted rabbit retinal tissue, and in vivo ocular necrosis and inflammation in rabbits (14).
Schoeni and Wong (25) previously reported that HBL was secreted by over 200 B. cereus, B. thuringiensis, and B. mycoides strains tested. Beattie and Williams (2) showed that the supernatant fluids from isolates of B. thuringiensis, B. circulans, B. licheniformis, B. lentus, B. laterosporus, and B. mycoides reacted positively with both the BDE and the RPLA immunoassays. B. subtilis, B. licheniformis, B. pumilus, and B. thuringiensis were previously implicated in outbreaks of food-borne disease (13, 24). It has been shown that some B. cereus strains may contain multiple copies of the hbl genes that arose from duplication of a single gene (25). HBL has been mapped to a portion of the B. cereus chromosome that exhibits exceptional variability compared with other regions, and this variable region is sometimes located on large extrachromosomal DNA fragments that appear to be stable but may prove to be large mobile plasmids (25). These findings may explain why many different Bacillus species appear to have the B. cereus-associated HBL enterotoxin complex.
This study recognizes the existence of lecithinase-positive toxigenic B. licheniformis strains isolated from the clinical environment. Interestingly, of the 23 toxin-producing isolates of B. licheniformis previously reported, all were incapable of producing lecithinase (24). The production of lecithinase, other phospholipases, proteases, and enterotoxins is recognized as a putative virulence factor that is required by invasive bacterial pathogens to elicit successful systemic infections (8, 19). The identification of lecithinase activity in clinical isolates of B. licheniformis is significant (possibly arising from genetic exchanges with the ubiquitous B. cereus), as this finding suggests that toxigenic B. licheniformis isolates may also acquire the necessary virulence determinants to support infection; lecithinase-positive B. pumilus KD14 was associated with a patient who had spreading fasciitis.
While a number of Bacillus species have been occasionally associated with gastrointestinal illnesses, recent evidence suggests that many members of this genus may be the cause of serious systemic diseases, such as septicemia, endocarditis, peritonitis, ophthalmitis, liver failure, and meningitis (8, 15, 24). We have shown that 21 Bacillus isolates representing 14 different species can invade HEp-2 and Caco-2 epithelial cells. Interestingly, the nutritional composition of the growth medium influenced bacterial virulence factor expression, such that baby foods containing both glucose syrup and lactose supported growth and enhanced levels of invasion in HEp-2 cells. Environmental signals, such as the presence of a readily utilizable carbon source, have been previously shown to modulate virulence factor expression in other bacterial enteropathogens (18, 20). PrfA, the central virulence transcriptional activator in L. monocytogenes, is regulated by a variety of environmental cues (18). This study has also provided evidence for expressional cross talk between environmental signals and virulence in Bacillus species. For instance, many of the clinical and food isolates of Bacillus were shown to contain DNA sequences encoding the HBL complex, yet only certain Bacillus isolates expressed the necessary hblA, hblC, and hblD genes to produce this diarrheal toxin after growth in reconstituted IMF products and in BHI broth.
In summary, this study has shown that a variety of different Bacillus spp. isolated from clinical specimens and food samples were capable of adhering to, invading, and producing cytotoxic effects in epithelial cells after growth in reconstituted IMF. While many different Bacillus isolates were shown to possess DNA sequences associated with the bceT, hblA, hblC, and hblD diarrheal enterotoxin genes, the composition of the bacterial culture medium influenced the ability of these Bacillus isolates to express these genes. It should be noted that reconstituted IMF were used as test food matrices in this study, as these products are frequently contaminated with acceptably low numbers of Bacillus spores (22). Properly reconstituted IMF containing Bacillus spp. have not been previously associated with food-borne illness in infants.
| |
ACKNOWLEDGMENTS |
|---|
This work was largely supported by the Chief Scientist Office, Scottish Executive, Edinburgh, Scotland (K/MRS/50/C2673). Thararat Chaithong thanks the government of Thailand for financial support.
We are grateful to V. Gill and M. Hughes for excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Bioscience, University of Strathclyde, Royal College, 204 George St., Glasgow G1 1XW, Scotland. Phone: 44 (0)141 548 2531. Fax: 44 (0)141 553 4124. E-mail: n.j.rowan{at}strath.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Agata, N.,
M. Ohta,
Y. Arakawa, and M. Mori.
1995.
The bceT gene of Bacillus cereus encodes an enterotoxic protein.
Microbiology
141:983-988 |
| 2. | Beattie, S. H., and A. G. Williams. 1999. Detection of toxigenic strains of Bacillus cereus and other Bacillus spp. with an improved cytotoxicity assay. Lett. Appl. Microbiol. 28:221-225[CrossRef][Medline]. |
| 3. |
Beecher, J. D., and A. C. L. Wong.
2000.
Tripartite haemolysin BL: isolation and characterization of two distinct homologous sets of components from a single Bacillus cereus isolate.
Microbiology
146:1371-1380 |
| 4. | Chaithong, T. 2000. A molecular genetic investigation of enterotoxigenic factors in Bacillus cereus. Ph.D. thesis. University of Strathclyde, Glasgow, Scotland. |
| 5. | Coote, J. G., and T. Arian. 1996. A rapid, colorimetric assay for cytotoxin activity in Campylobacter jejuni. FEMS Immunol. Med. Microbiol. 13:65-70[CrossRef][Medline]. |
| 6. | Craig, F. F., R. Dalgleish, and A. D. Sutherland. 1990. A colorimetric, microplate assay for the leucotoxin of Pasteurella haemolytica. Vet. Microbiol. 22:309-340[CrossRef][Medline]. |
| 7. |
Dietrich, R.,
C. Fella,
S. Stich, and E. Märtlbauer.
1999.
Production and characterization of monoclonal antibodies against the hemolysin BL-enterotoxin complex produced by Bacillus cereus.
Appl. Environ. Microbiol.
65:4470-4474 |
| 8. |
Drobniewski, F. A.
1993.
Bacillus cereus and related species.
Clin. Microbiol. Rev.
6:324-338 |
| 9. |
Findlay, W. J. J.,
N. A. Logan, and A. D. Sutherland.
1999.
Semiautomated metabolic staining assay for Bacillus cereus emetic toxin.
Appl. Environ. Microbiol.
65:1811-1812 |
| 10. | Granum, P. E., and T. Lund. 1997. Bacillus cereus and its food poisoning toxins. FEMS Microbiol. Lett. 157:223-228[CrossRef][Medline]. |
| 11. |
Hansen, B. M., and N. B. Hendriksen.
2001.
Detection of enterotoxigenc Bacillus cereus and Bacillus thuringiensis strains by PCR analysis.
Appl. Environ. Microbiol.
67:185-189 |
| 12. |
Helgason, E.,
O. A. Okstad,
D. A. Caugant,
H. A. Johansen,
A. Fouet,
M. Mock,
I. Hegna, and A.-B. Kolsto.
2000.
Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis one species on the basis of genetic evidence.
Appl. Environ. Microbiol.
66:2627-2630 |
| 13. | Jackson, S. G., R. B. Goodbrand, R. Ahmed, and S. Kasatiya. 1995. Bacillus cereus and Bacillus thuringiensis isolated in a gastroenteritis outbreak investigation. Lett. Appl. Microbiol. 21:103-105[Medline]. |
| 14. | Kotiranta, A., K. Lounatmaa, and M. Haapasalo. 2000. Epidemiology and pathogenesis of Bacillus cereus infections. Microbes Infect. 2:189-198[CrossRef][Medline]. |
| 15. | Mahler, H., A. Pasi, J. M. Kramer, P. Schulte, A. C. Scoging, W. Baer, and S. Kraehenbuehl. 1997. Fulminant liver failure associated with the emetic toxin of Bacillus cereus. N. Engl. J. Med. 336:1143-1148. |
| 16. |
Mäntynen, V., and K. Lindström.
1998.
A rapid PCR-based DNA test for enterotoxic Bacillus cereus.
Appl. Environ. Microbiol.
64:1634-1639 |
| 17. | Notermans, S., and C. A. Batt. 1998. A risk assessment approach for food-borne Bacillus cereus and its toxins. J. Appl. Microbiol. Symp. Suppl. 84:51S-61S. |
| 18. | Rowan, N. J. 1999. Evidence that inimical food preservation barriers alter microbial resistance, virulence and cell morphology. Trends Food Sci. Technol. 10:261-272[CrossRef]. |
| 19. |
Rowan, N. J.,
A. A. G. Candlish,
A. Bubert,
J. G. Anderson,
K. Kramer, and J. McLauchlin.
2000.
Virulent rough filaments of Listeria monocytogenes from clinical and food samples secreting wild-type levels of cell-free p60 protein.
J. Clin. Microbiol.
38:2643-2648 |
| 20. | Rowan, N. J., and J. G. Anderson. 1997. Maltodextrin stimulates growth of Bacillus cereus and synthesis of diarrheal enterotoxin in infant milk formulae. Appl. Environ. Microbiol. 63:1182-1184[Abstract]. |
| 21. | Rowan, N. J., and J. G. Anderson. 1998. Growth and enterotoxin production by diarrhoeagenic Bacillus cereus in dietary supplements prepared for hospitalised HIV patients. J. Hosp. Infect. 38:139-146[CrossRef][Medline]. |
| 22. | Rowan, N. J., J. G. Anderson, and A. Anderton. 1997. Bacteriological quality of infant milk formulae examined under a variety of preparation and storage conditions. J. Food Prot. 60:1089-1094. |
| 23. |
Ryan, P. A.,
J. D. Macmillan, and B. A. Zilinkas.
1997.
Molecular cloning and characterization of the genes encoding the L1 and L2 components of hemolysin BL from Bacillus cereus.
J. Bacteriol.
179:2551-2556 |
| 24. |
Salkinoja-Salonen, M. S.,
R. Vourio,
M. A. Andersson,
P. Kampfer,
M. C. Andersson,
T. Honkanen-Buzalski, and A. C. Scoging.
1999.
Toxigenic strains of Bacillus licheniformis related to food poisoning.
Appl. Environ. Microbiol.
65:4637-4645 |
| 25. | Schoeni, J. L., and A. C. L. Wong. 1999. Heterogeniety observed in the components of hemolysin BL, an enterotoxin produced by Bacillus cereus. Int. J. Food Microbiol. 53:159-167[CrossRef][Medline]. |
| 26. | von Dietrich, R., K. Mauersberger, and E. Martlbauer. 1997. Zur anwendbarkeit des MTT zytotoxizitatstests zum nachwies von B. cereus enterotoxin. Arch. Lebensmittelhyg. 48:73-96. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»